{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T19:58:32Z","timestamp":1694635112762},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1097\/aci.0b013e3282f64802","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T15:54:51Z","timestamp":1236268491000},"page":"158-162","source":"Crossref","is-referenced-by-count":4,"title":["Management of asthma in preschool children with inhaled corticosteroids and leukotriene receptor antagonists"],"prefix":"10.1097","volume":"8","author":[{"given":"Leonard B","family":"Bacharier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-12-20210203","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1056\/NEJM199501193320301","article-title":"Asthma and wheezing in the first six years of life","volume":"332","author":"Martinez","year":"1995","journal-title":"N Engl J Med"},{"key":"R2-12-20210203","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1164\/ajrccm\/146.4.888","article-title":"A community-based study of the epidemiology of asthma","volume":"146","author":"Yunginger","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"R3-12-20210203","first-page":"1","article-title":"National Surveillance for Asthma: United States, 1980-2004.","volume":"56","year":"2007","journal-title":"MMWR Surveillance Summaries"},{"key":"R4-12-20210203","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1081-1206(10)62646-4","article-title":"Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children","volume":"83","author":"Kemp","year":"1999","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R5-12-20210203","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1542\/peds.103.2.414","article-title":"A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants","volume":"103","author":"Baker","year":"1999","journal-title":"Pediatrics"},{"key":"R6-12-20210203","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1542\/peds.113.2.e87","article-title":"Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing","volume":"113","author":"Bisgaard","year":"2004","journal-title":"Pediatrics"},{"key":"R7-12-20210203","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.rmed.2005.04.008","article-title":"The efficacy and safety of fluticasone propionate in very young children with persistent asthma symptoms","volume":"99","author":"Carlsen","year":"2005","journal-title":"Respir Med"},{"key":"R8-12-20210203","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S1081-1206(10)61343-9","article-title":"Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study","volume":"96","author":"Wasserman","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R9-12-20210203","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jpeds.2006.07.045","article-title":"Efficacy and safety of fluticasone propionate hydrofluoroalkane inhalation aerosol in preschool-age children with asthma: A randomized, double-blind, placebo-controlled study","volume":"149","author":"Qaqundah","year":"2006","journal-title":"J Pediatr"},{"key":"R10-12-20210203","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1056\/NEJMoa051378","article-title":"Long-term inhaled corticosteroids in preschool children at high risk for asthma","volume":"354","author":"Guilbert","year":"2006","journal-title":"N Engl J Med"},{"key":"R11-12-20210203","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1164\/rccm.200408-1088OC","article-title":"Fluticasone improves pulmonary function in children under 2 years old with risk factors for asthma","volume":"171","author":"Teper","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R12-12-20210203","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1164\/rccm.200402-227OC","article-title":"Efficacy of fluticasone propionate on lung function and symptoms in wheezy infants","volume":"171","author":"Hofhuis","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R13-12-20210203","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/ppul.20055","article-title":"Inhaled fluticasone dipropionate decreases levels of nitric oxide in recurrenty wheezy infants","volume":"38","author":"Moeller","year":"2004","journal-title":"Pediatr Pulmonol"},{"key":"R14-12-20210203","doi-asserted-by":"crossref","first-page":"E48","DOI":"10.1542\/peds.108.3.e48","article-title":"Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years","volume":"108","author":"Knorr","year":"2001","journal-title":"Pediatrics"},{"key":"R15-12-20210203","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1164\/ajrccm.172.6.954","article-title":"Montelukast for viral respiratory infection-induced exacerbations of asthma","volume":"172","author":"Bisgaard","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R16-12-20210203","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1164\/rccm.200510-1546OC","article-title":"Short course montelukast for intermittent asthma in children: a randomized controlled trial","volume":"175","author":"Robertson","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"R17-12-20210203","doi-asserted-by":"crossref","first-page":"e702","DOI":"10.1542\/peds.2006-3317","article-title":"Attenuation of the September epidemic of asthma exacerbations in children: a randomized, controlled trial of montelukast added to usual therapy","volume":"120","author":"Johnston","year":"2007","journal-title":"Pediatrics"},{"key":"R18-12-20210203","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1378\/chest.06-1402","article-title":"The effect of montelukast on bronchial hyperreactivity in preschool children","volume":"131","author":"Hakim","year":"2007","journal-title":"Chest"},{"key":"R19-12-20210203","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1183\/09031936.05.00031904","article-title":"The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthma","volume":"25","author":"Straub","year":"2005","journal-title":"Eur Respir J"},{"key":"R20-12-20210203","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1378\/chest.127.2.509","article-title":"The effect of montelukast on exhaled nitric oxide and lung function in asthmatic children 2\u20135 years old","volume":"127","author":"Straub","year":"2005","journal-title":"Chest"},{"key":"R21-12-20210203","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaci.2004.11.014","article-title":"Characterization of within-subject responses to fluticasone and montelukast in childhood asthma","volume":"115","author":"Szefler","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"R22-12-20210203","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaci.2005.10.012","article-title":"Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma","volume":"117","author":"Zeiger","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"R23-12-20210203","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1542\/peds.2004-1172","article-title":"Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study","volume":"116","author":"Garcia Garcia","year":"2005","journal-title":"Pediatrics"},{"key":"R24-12-20210203","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jpeds.2005.03.052","article-title":"Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthma","volume":"147","author":"Ostrom","year":"2005","journal-title":"J Pediatr"},{"key":"R25-12-20210203","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaci.2006.09.042","article-title":"Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: The Pediatric Asthma Controller Trial","volume":"119","author":"Sorkness","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"R26-12-20210203","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jaci.2007.08.063","article-title":"Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma","volume":"120","author":"Szefler","year":"2007","journal-title":"J Allergy Clin Immunol"}],"container-title":["Current Opinion in Allergy & Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACI.0b013e3282f64802","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T16:46:55Z","timestamp":1636562815000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130832-200804000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/aci.0b013e3282f64802","relation":{},"ISSN":["1528-4050"],"issn-type":[{"value":"1528-4050","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}